SOURCE: IO Circuit

August 14, 2013 08:30 ET Announces Trade Alerts on: BCLI, ACTC, CERP, and APDN

NOTE TO EDITORS: The Following Is an Investment Opinion Issued by the IO Circuit

NEW YORK, NY--(Marketwired - Aug 14, 2013) - focuses on identifying the hottest small cap companies in today's market. We are the #1 source for the best penny stocks alerts.

Alerts for today are issued on the following stocks: BCLI, ACTC, CERP, and APDN

Brainstorm Cell Therapeutics Inc. (OTCQB: BCLI) -- traded over 7.5 million shares on Tuesday in comparison to an average of 160,000 shares. The Company announced the pricing of a $4.0 million underwritten public offering of 23,529,411 units. Shares closed down 17.62%.

You can read more about BCLI here:

Advanced Cell Technology Inc. (OTCQB: ACTC) -- closed down roughly 3% on Tuesday with a significant boost in volume. The stock traded nearly 27 million shares in comparison to an average of around 9.3 million shares.

You can read more about ACTC here:

Cereplast, Inc. (OTCQB: CERP) -- closed up 15.77% on Tuesday with over 78 million shares traded. The stock is now up over 40% in the past two trading days.

You can read more about CERP here:

Applied DNA Sciences Inc. (OTCQB: APDN) -- shares were little changed in price on Tuesday though the stock saw a jump in volume, trading a little over 5 million shares. The Company announced its financial results for the third fiscal quarter ending June 30, 2013.

You can read more about APDN here:

For more promising small-cap companies that look poised for upside growth, visit:

This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid IO Circuit one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. No representation, expressed or implied, is made as to the accuracy, completeness or correctness. We accept no liability for any losses arising from an investor's reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

Contact Information